CONTROVERSIAL ASPECTS OF CYTOREDUCTIVE SURGERY IN EPITHELIAL OVARIAN-CANCER

被引：17
作者：
HACKER, NF [1 ]
机构：
[1] ROYAL HOSP WOMEN,GYNAECOL ONCOL,PADDINGTON 2021,AUSTRALIA
来源：
BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY | 1989年 / 3卷 / 01期
关键词：
D O I：
10.1016/S0950-3552(89)80041-0
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：49 / 57
页数：9
相关论文
共 30 条
  • [21] CHANGING PROGNOSIS AND TREATMENT IN CANCER OF OVARY - A REPORT OF 235 PATIENTS WITH PRIMARY OVARIAN CARCINOMA 1952-1961
    MUNNELL, EW
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1968, 100 (06) : 790 - &
  • [22] RANDOMIZED TRIAL COMPARING 2 COMBINATION CHEMOTHERAPY REGIMENS (CHAP-5 V CP) IN ADVANCED OVARIAN-CARCINOMA
    NEIJT, JP
    TENBOKKELHUININK, WW
    VANDERBURG, MEL
    VANOOSTEROM, AT
    WILLEMSE, PHB
    HEINTZ, APM
    VANLENT, M
    TRIMBOS, JB
    BOUMA, J
    VERMORKEN, JB
    VANHOUWELINGEN, JC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) : 1157 - 1168
  • [23] IMMUNODIAGNOSIS IN OVARIAN-CANCER - BLOCKING FACTOR ACTIVITY
    PATTILLO, RA
    RUCKERT, ACF
    STORY, MT
    MATTINGLY, RF
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1979, 133 (07) : 791 - 802
  • [24] SILBERMAN AW, 1982, SURG GYNECOL OBSTET, V155, P577
  • [25] SKIPPER H E, 1964, Cancer Chemother Rep, V35, P1
  • [26] THOUGHTS ON CANCER CHEMOTHERAPY AND COMBINATION MODALITY THERAPY (1974)
    SKIPPER, HE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 230 (07): : 1033 - 1035
  • [27] TANNOCK I, 1978, CANCER TREAT REP, V62, P1117
  • [28] VANLINDERT ACM, 1984, SURGERY GYNECOLOGICA
  • [29] 1987, LANCET, V2, P353
  • [30] 1986, GYNECOL ONCOL, V23, P1
123